Experienced in Subvalvular Aortic Stenosis

Masliza Mahmod

Headley Way, 
Oxford, ENG, GB 
Experienced in Subvalvular Aortic Stenosis
Headley Way, 
Oxford, ENG, GB 
OverviewLocationsClinical Research

Overview

Masliza Mahmod practices in Oxford, United Kingdom. Mahmod is rated as an Experienced expert by MediFind in the treatment of Subvalvular Aortic Stenosis. Their top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Aortic Valve Stenosis, and Heart Failure with Preserved Ejection Fraction (HFpEF).

Their clinical research consists of co-authoring 55 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have participated in 2 clinical trials in the study of Subvalvular Aortic Stenosis.

Locations

Headley Way, Oxford, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised, Double-blind, Placebo-controlled, Phase 2 Evaluation of the Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
A Randomised, Double-blind, Placebo-controlled, Phase 2 Evaluation of the Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Drug
Study Drug: Trientine
Study Phase: Phase 2
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Enrollment Status: Active_not_recruiting
Publish Date: December 13, 2024
Intervention Type: Other
View 1 Less Clinical Trial

55 Total Publications

Targeting Cardiac Metabolism in Heart Failure with PPARα Agonists: A Review of Preclinical and Clinical Evidence.
Targeting Cardiac Metabolism in Heart Failure with PPARα Agonists: A Review of Preclinical and Clinical Evidence.
Journal: Biomedicines
Published: June 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mahmod's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile